DIVI S LABORATORIES LTD Valuation

DIVISLAB · Healthcare · Current price ₹9,140

Full stock page
DocStoX fair value
₹2,876
low confidence
Current price
₹9,140
Upside
-68.5%
P/E ratio
94.5x
P/B ratio
10.6x
Verdict
Avoid
Model it yourself — Earnings Yield Calculator
Opens pre-filled with DIVI S LABORATORIES LTD's latest numbers.

Is DIVI S LABORATORIES LTD undervalued?

DocStoX estimates the fair value of DIVI S LABORATORIES LTD at ₹2,876 per share, versus the current market price of ₹9,140. That puts the stock about -68.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹774), Relative P/E (₹3,783), Graham floor (₹1,172), Analyst target (₹8,332). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹774 (bear) to ₹2,876 (base) to ₹8,332 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Valuation multiples

DIVI S LABORATORIES LTD trades at a P/E of 94.5x and a P/B of 10.6x, with a dividend yield of 0.3%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on DIVI S LABORATORIES LTD

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.